About this trial

The primary objective of this study is to obtain long-term implant survivorship (out to 10 years) and to assess clinical, patient-reported outcome measures, and radiographic data for the commercially available Physica system. For ancillary arm, from baseline to 5-year follow-up.

Eligibility criteria

Qualifiers

Males and females of any race requiring a total knee replacement and suitable for the use of one of the configurations of the Physica system

Age> 22 (skeletally mature)

Suitable candidates for TKR who have undamaged and functional collateral ligaments

Suitable candidates for TKR with Physica KR, CR, who have an undamaged and functional posterior cruciate ligament; or Physica LMC with or without a functioning posterior cruciate ligament or Physica PS with an absent or not-functioning posterior cruciate ligament and/or severe antero-posterior instability of the knee joint

Disqualifiers

Patients with severe instability of the knee joint secondary to the absence of collateral ligament integrity and/or function

Patients with active or any suspected infection (on the affected knee or systemic)

Previous partial knee replacement (unicompartimental, bicompartimental or patellofemoral joint replacement), patellectomy, high tibial osteotomy

Patients with significant bone loss on femoral or tibial joint side

Trial design

Treatments tested in this trial

  • Physica Kinematic Retaining Knee System
  • Physica Cruciate Retaining Knee System
  • Physica Posterior Stabilized Knee System
  • Physica Cruciate Retaining Knee System with LMC Liner

Treatment groups

800 Participants
are divided into 4 treatment groups

Locations

5
Eisenhower Desert Orthopedics Center - Harry and Diane Rinker Bldg92270, Rancho MirageCalifornia, United States
The Orthopedics Clinic32117, Daytona BeachFlorida, United States
Rush Castle Orthopaedics60504, AuroraIllinois, United States
Syracuse Orthopedic Specialists13214, SyracuseNew York, United States

Sponsors and collaborators

Limacorporate S.p.a

Lead sponsor